Stanford Center for Magnetic Nanotechnology
The Wang Group
About Dr. Chen:
Dr. Zuxiong Chen is a Senior Research Scientist in the Department of Urology at Stanford University. His current research focuses on using magneto-nanochips to develop panel biomarker assays for prostate cancer early detection and management. Dr. Chen has been involved in prostate cancer biomarker research since 1992. His pioneering efforts led to establishment of the first international standards of prostate specific antigen (PSA) and PSA 90:10. He has used laser captured microdissection (LCM), DNA microarray, proteomics, and glycomics technologies to study prostate cancer samples, from which he purified and characterized benign prostatic hyperplasia (BPH) PSA, BPH-PSA, developed several useful monoclonal antibodies for prostate cancer studies. Dr. Chen has published over 30 papers.
Please contact Dr. Zuxiong Chen by email.
Education
1978-1982: BA in Medicine, Shanghai Second Medical University, Shanghai, China
1978-1983: Resident, Department of Surgery, Zarbei Central Hospital, Shanghai, China
1986-1992: Ph.D. in Biochemistry, University of Georgia, Athens, GA
1992-1995: Postdoctoral training, Department of Urology, Stanford University
E-mail: zxchen [@] stanford [dot] edu
Dr. Zuxiong Chen